We present ChildVox, a novel benchmark for characterizing the diverse acoustic signals through which children communicate. Specifically, ChildVox follows the full developmental trajectory from birth through school age, covering physiological sounds, non-linguistic vocalizations, canonical syllables, and spoken language. ChildVox integrates more than 20 sub-tasks across 17 child-centered audio and speech datasets, enabling systematic cross-corpus and cross-domain comparison. We evaluate a representative range of audio and speech foundation models, including self-supervised, ASR-oriented, and large audio-language models, on tasks including physiological sound classification, vocalization and canonical syllables modeling, and speech quality assessment and recognition. Benchmark results show that ChildVox provides a suite of high-performance models in recognizing a wide range of acoustic signals from children, supporting downstream applications such as characterizing children’s language levels and tracking speech production with age. Our benchmark models on public datasets are released at: https://github.com/tiantiaf0627/childvox-release.

Respiratory diseases remain a leading cause of global mortality, where timely and accurate diagnosis is critical to improving patient outcomes and reducing healthcare burdens. While prior work has explored audio-based models for respiratory disease detection, such unimodal approaches often suffer from limited generalizability and diagnostic precision. In this paper, we propose RespiraMFM, a Multimodal Foundation Model that integrates respiratory sounds with patient medical history and symptoms to enhance diagnostic accuracy and disease detection capabilities. We introduce an effective contrastive alignment strategy for audio-text multimodal integration, allowing the model to learn better cross-modal representations between respiratory sounds and corresponding textual clinical information. We evaluate RespiraMFM across five major respiratory diseases using seven real-world datasets in both supervised fine-tuning and zero-shot settings, achieving a 9.15% improvement in AUROC on supervised tasks and a 20.98% gain on zero-shot tasks over existing baselines. These findings underscore the potential of our framework to advance early diagnosis and improve clinical decision-making in respiratory disease management.